SCHEMBL31066104

SCHEMBL31066104

C[C@]1(O)CCCN(c2cccc(N)n2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 5/20 0.44
▸ GRIN2D O15399 1/20 0.43
▸ GRIN3B O60391 1/20 0.43
▸ GRIN1 Q05586 1/20 0.43
▸ GRIN2A Q12879 1/20 0.43
▸ GRIN2B Q13224 1/20 0.43
▸ GRIN2C Q14957 1/20 0.43
▸ GRIN3A Q8TCU5 1/20 0.43
▸ KIF18A Q8NI77 3/20 0.42
▸ HSD11B1 P28845 1/20 0.41
▸ ACACB O00763 1/20 0.37
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ JAK2 O60674 3/20 0.36
▸ TYK2 P29597 3/20 0.36
▸ PTPN11 Q06124 1/20 0.36
▸ PRKCQ Q04759 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22163218 1.00 PIM1 (0.44) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL22471258 0.85 GRIN2B (0.46) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30464684 0.85 GRIN2B (0.46) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL22163226 0.81 KIF18A (0.44) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31066073 0.81 KIF18A (0.44) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL14890189 0.79 GRIN2D (0.48) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL18278380 0.76 FFAR2 (0.43) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL465738 0.76 GRIN2D (0.57) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1809857 0.76 GRIN2D (0.57) PIM1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL14890661 0.75 GRIN2D (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441736-B2 KIF18A inhibitors AMGEN INC. (US) 2025-10-14 — — US disclosed
EP-3898592-B1 HETEROARYL AMIDES USEFUL AS KIF18A INHIBITORS AMGEN INC (US) 2024-10-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441736-B2 KIF18A inhibitors KIF18A, KIF18B, KIF15 PIM1 3477/4885GRIN2D 4395/4885GRIN3B 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback